Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

Eve T. Rodler, Gabriel N. Hortobágyi, William E. Barlow et al.|The Lancet Oncology|2023

Cited by 103